Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bacterial Resistance to Antimicrobial”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07093593
What this trial is testing

Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs

Who this might be right for
Cervical CancersEndometrial CancerGynecological Cancers+2 more
Centre Georges Francois Leclerc 260
Not applicableStudy completedNCT00235690
What this trial is testing

Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)

Who this might be right for
BacteremiaPseudomonas Infections
University of Pittsburgh 10
Post-approval studies (Phase 4)UnknownNCT01572597
What this trial is testing

Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy

Who this might be right for
Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Buddhist Tzu Chi General Hospital 120
Not applicableStudy completedNCT05171257
What this trial is testing

Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit

Who this might be right for
Gram-Negative Bacterial Infections
Methodist Health System 197
Not applicableStudy completedNCT02852902
What this trial is testing

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.

Who this might be right for
Clinically Significant BacteremiaOrgan TransplantationInfection+6 more
Spanish Network for Research in Infectious Diseases 820
Not applicableStudy completedNCT00167986
What this trial is testing

Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care

Who this might be right for
Escherichia Coli InfectionsKlebsiella Infections
Wyeth is now a wholly owned subsidiary of Pfizer 480
Not applicableStudy completedNCT02796716
What this trial is testing

Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections

Who this might be right for
INFECTIONSSkin and Subcutaneous Tissue Bacterial InfectionsHealthcare-associated Infection+1 more
Denver Health and Hospital Authority 2,102
Testing effectiveness (Phase 2)Looking for participantsNCT04759001
What this trial is testing

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 52
Not applicableStudy completedNCT07172932
What this trial is testing

ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT

Who this might be right for
Bloodstream InfectionsEnterobacteriaceae InfectionsIntensive Care (ICU)+1 more
Ankara City Hospital Bilkent 314
Not applicableStudy completedNCT04764500
What this trial is testing

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

Who this might be right for
Extended Spectrum Beta Lactamases (ESBL) E. Coli
University Hospital, Basel, Switzerland 39
Post-approval studies (Phase 4)Not Yet RecruitingNCT07203846
What this trial is testing

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

Who this might be right for
ACS - Acute Coronary SyndromeTicagrelorMicrobiota+10 more
Collegium Medicum w Bydgoszczy 50
Testing effectiveness (Phase 2)Study completedNCT03638830
What this trial is testing

Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa

Who this might be right for
Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas AeruginosaPseudomonas Infections+1 more
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 777
Not applicableStudy completedNCT00000947
What this trial is testing

Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 850
Not applicableLooking for participantsNCT06824350
What this trial is testing

Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

Who this might be right for
SepsisNeonatal MortalityAntibiotic Resistant Infection+2 more
University of California, Berkeley 45,450
Early research (Phase 1)Study completedNCT01855048
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers

Who this might be right for
Healthy VolunteersAnti-Bacterial AgentsMethicillin-Resistant Staphylococcus Aureus
Intron Biotechnology, Inc. 36
Large-scale testing (Phase 3)Study completedNCT03545373
What this trial is testing

Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study)

Who this might be right for
TuberculosisRespiratory Tract InfectionsPneumonia
London School of Hygiene and Tropical Medicine 1,583
Not applicableEnded earlyNCT01820793
What this trial is testing

Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli

Who this might be right for
Acute Pyelonephritis Without Severity Symptoms Due to ESBL-producing E.Coli
Assistance Publique - Hôpitaux de Paris 9
Early research (Phase 1)Study completedNCT03446053
What this trial is testing

Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers

Who this might be right for
Healthy VolunteersAnti-Bacterial AgentsMethicillin-Resistant Staphylococcus Aureus+1 more
Intron Biotechnology, Inc. 33
Not applicableUnknownNCT05942157
What this trial is testing

Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections

Who this might be right for
SepsisHemodynamic InstabilityBacterial Infections+2 more
Singapore General Hospital 810
Testing effectiveness (Phase 2)Study completedNCT01595529
What this trial is testing

The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children"

Who this might be right for
Urinary Tract Infection
National Institute of Allergy and Infectious Diseases (NIAID) 717
Next Page